Skip to main content
. 2022 Jun 28;6(8):bvac099. doi: 10.1210/jendso/bvac099

Figure 5.

Figure 5.

Absolute and percentage change from baseline in hepatic triacylglycerol lipase and the relation of change in hepatic triacylglycerol lipase with the change in high-density lipoprotein (HDL) cholesterol concentrations. Point estimates, 95% CIs, and P values extracted from a mixed-model framework. P values are for overall dose effect and comparison between the 5 mg daily dose group and placebo groups.